When toxic shock syndrome toxin 1 was subjected to papain hydrolysis, two serologically active fragments of 16.3 kilodaltons (16K fragment) and 12.4 kilodaltons (12K fragment) were generated, whereas a third fragment of 9.7 kilodaltons (1OK fragment) was inactive. The biologic activities of the fragments were evaluated in vitro by determining their ability to promote nonspecific proliferation of human peripheral blood mononuclear cells. The 12K fragment was significantly (P c 0.013) more stimulatory than the 16K fragment. When human peripheral blood mononuclear cells were preincubated for a period of 24 h with various concentrations of the 16K fragment, followed by incubation with a constant amount (2 x 10-2 ng/ml) of whole toxin, the level of DNA synthesis induced by the holotoxin was reduced by approximately 60% when compared with that of controls exposed to whole toxin alone. The 12K fragment did not demonstrate a similar blocking effect. Immunoblots of the toxic shock syndrome toxin 1 digest, which were exposed to monoclonal antibodies (MAbs) developed against native toxin, depicted the presence of two different antigenic regions (epitopes). One MAb, 8-5-7, which has been shown previously to inhibit the biologic activity of the holotoxin in vitro and in vivo, reacted primarily with the 12K fragment. A second MAb, 10-6-1, that did not neutralize interleukin-1 production reacted primarily with the 16K fragment. On the basis of the differential mitogenic responses and the identification of heterologous epitopes, it was concluded that the functional region of the holotoxin can be partitioned into at least two functional segments encompassed between amino acid residues 53 and 87 and between amino acid residues 88 and 194 on the polypeptide chain.
Considerable progress has been made in elucidating the role of toxic shock syndrome toxin 1 (TSST-1) (10) as a causative agent for toxic shock syndrome. The biologic manifestations of the toxin have been elaborated and include the stimulation of nonspecific proliferation of T lymphocytes (7) ; induction of lymphokine secretion by lymphocytes (13) ; induction of fever consequent to the release of interleukin-1 (IL-1), tumor necrosis factor, and perhaps other cytokines and enhancement of host susceptibility to endotoxic shock (23) ; and deregulation of immunoglobulin synthesis (21) .
Studies of TSST-1 at the molecular level were initiated by Kreiswirth et al. (14) with the isolation and expression of the toxin structural gene in Escherichia coli. This enabled the prediction of the amino acid sequence of the entire polypeptide (22 kilodaltons [kDa] in molecular size) from the nucleotide sequence (4) .
Blomster-Hautamaa et al. (5) have studied a TSST-1 digest that was obtained by exposing the toxin to cyanogen bromide. A single functional region that is responsible for the mitogenic and immunosuppressive effects was suggested to be localized on a 14-kDa segment of the toxin that is encompassed between two methionine residues at positions 33 and 158 on the molecule. This assumption was based on the use of monoclonal antibodies (MAbs) developed against TSST-1 which reacted with fragments of the toxin digest that were immobilized on Western blots. The MAbs were determined to neutralize both biologic functions of the native toxin.
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We have described elsewhere the isolation and characterization of fragments of TSST-1 obtained through papain hydrolysis (8) . The fragments, designated the 16K, 12K, and 10K fragments, were determined to have molecular sizes of 16.3, 12.4 , and 9.7 kDa, respectively, as determined from the deduced amino acid sequences. The fragments were categorized as being active or inactive when they were subjected to immunologic and biologic in vitro analyses. The orientations of these fragments on the entire toxin molecule enabled the identification of the active portion of the toxin. It was found to lie between amino acid residues 53 and 194, toward the COOH-terminal end.
The possibility exists that the activities attributed to TSST-1 could be correlated with different regions of the polypeptide. In this report we delineate the assignment of two functional segments on the molecule. The identification of the antigenic regions was confirmed through immunoblotting by exposing Western blots of a papain-derived TSST-1 digest to MAbs with differential effects against certain biologic properties of the toxin. This observation was further substantiated by the determination that there was a variation in the associated biologic responses demonstrated by direct analyses of the 16K and 12K fragments in mitogenesis assays.
MATERIALS AND METHODS
Purified TSST-1 from sac culture preparations of Staphylococcus aureus MN8 (18) was kindly provided by Jeffrey Parsonnet (Channing Laboratory, Boston, Mass.). The toxin was lyophilized and stored at -20°C.
TSST-1 enzymatic digest. Toxin fragments were obtained through the proteolytic hydrolysis of TSST-1 with papain, as described previously (8) .
Recovery of toxin fragments. The TSST-1 digest was subjected to sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) in the presence of 0.1% SDS by the procedure of Laemmli (16) , which was modified for preparative purposes as described previously (8) .
The proteins from the gels were eluted into 10 mM ammonium bicarbonate buffer-0.05% Tween 20 (pH 8.0) or 10 mM Bis-Tris (bis [2-hydroxyethyl] imino-tris[hydroxymethyl]methane)-70 mM sodium chloride-10 mM sodium bicarbonate-0.005% bovine serum albumin (pH 7.4) for 18 to 24 h at 4°C. The eluates were maintained at 4°C or were frozen at -200C.
Estimation of immunologically active material. The gel eluates were diluted 100-fold in phosphate-buffered saline supplemented with 40 mM MgSO4 7H20-0. 1% bovine serum albumin-0.2% sodium azide-0.05% Tween 20 (pH 7.4). The samples were analyzed by a competitive enzyme-linked immunosorbent assay (ELISA) (19) . The quantities of active material were computed (in nanograms per milliliter) from calibration curves generated with purified TSST-1 standards in the range of 1 to 60 ng/ml.
Reactivity of TSST-1 and associated fragments with MAbs. Four samples of ascitic fluid containing murine MAbs (developed against whole TSST-1 [kindly provided by Peter Bonventre, University of Cincinnati Medical Center, Cincinnati, Ohio]) were used. The MAbs were selected on the basis of their different abilities to neutralize the effect of TSST-1 in inducing IL-1 secretion by human macrophages (6) . Two MAbs, designated 8-5-7 and 6-1-1, were shown to inhibit IL-1 production, while the other two MAbs, designated 13-2-6 and 10-6-1, did not block this action of TSST-1.
The relative affinities of the MAbs were estimated on the basis of the dilution factor at which 50% plateau binding occurred (9) . The concentrations of the MAbs were adjusted based on their relative affinities, so that all the MAbs showed approximately equivalent reactivities (optical density values) when they were tested against native TSST-1-coated microtiter plates.
Immunoblotting. A TSST-1 digest was subjected to SDS-PAGE through a 17% polyacrylamide gel in the presence of 0.1% SDS and electroeluted onto a polyvinylidene difluoride (PVDF) Estimation of biologic activity. The toxin fragments and whole toxin were tested for their ability to induce nonspecific proliferation of human T lymphocytes (20) . Heparinized whole blood from healthy adults was subjected to density gradient centrifugation through lymphocyte separation medium (Litton Bionetics, Charleston, S.C.). Inhibition of biologic activity. The abilities of the 12K and 16K fragments to inhibit the mitogenic activity of the holotoxin were tested. The serologic activities of the 12K and 16K fragments and the holotoxin (gel eluates diluted in RPMI 1640 medium) were determined by a competitive ELISA. Various concentrations of the fragments which were :-10-or -<10-fold of a concentration of 2 x 10-2 ng/ml were added in 50-,u volumes to human PBMs, which were cultured in 100-,u volumes at a concentration of 3 x 106 cells per ml. The culture plates were initially incubated at 37°C in VOL. 57, 1989 on September 30, 2017 by guest http://iai.asm.org/ Downloaded from 5% CO2 for 24 h. Equal volumes (50 ,ul) of gel eluates containing whole toxin adjusted to a concentration of 2 x 10-2 ng/ml were then added to the wells. Subsequent steps were patterned as described above. Control cultures with whole toxin, fragments, or medium were maintained simultaneously.
Timed inhibition assays were performed by varying the initial incubation period of the PBMs with 16K fragments for 40 min, 6 h, and 24 h before the addition of whole toxin.
The percentage of inhibition was determined by the following formula: {1 -[mean dpm of test wells (cultures exposed to fragment and toxin)/mean dpm of control wells (cultures exposed to whole toxin alone)]} x 100.
Statistics. The significance of differences between proliferative responses was evaluated by Student's t test of unpaired data sets.
RESULTS
Purified TSST-1 was hydrolyzed with papain, generating three major peptide fragments. The molecular sizes derived from the predicted amino acid sequences were determined to be 16.3, 12.4, and 9.7 kDa for the 16K, 12K, and 10K fragments, respectively. Serologic activity was analyzed by using either polyclonal antibodies or MAbs developed against native TSST-1 through competitive saturation analysis, and immunoblotting was demonstrated only by the 16K and 12K fragments. Furthermore, the 12K fragment demonstrated mitogenic activity (8) .
Seven MAbs in ascitic fluid which were developed against native TSST-1 were previously tested against Western blots of a TSST-1 digest. The MAbs (ascitic fluid) were used at a constant dilution of 1:104. Six MAbs reacted with whole toxin and the 16K and 12K fragments. One MAb, 10-6-1, however, identified only whole toxin and the 16K fragment. No bands were apparent with control blots exposed to the goat anti-mouse alkaline phosphatase conjugate alone, suggesting that the minor bands that were present could be degradation products of the toxin (8) .
Attempts were then made to confirm the specificity of reactivity of four of the MAbs with the 16K and 12K fragments. The MAbs were selected on the basis of their ability to neutralize the stimulation of IL-1 production. Two MAbs, 8-5-7 and 6-1-1, neutralized the effect described above, whereas the other MAbs, 13-2-6 and 10-6-1, were ineffective (6) .
The endpoint titers of the MAbs were initially determined by screening sequential dilutions of ascitic fluids in ELISA microtiter plates coated with whole toxin. The relative titers of the MAbs were correlated with the dilution that demonstrated 50% plateau binding in dose-response curves (9, 24) . had the highest titer, with 50% plateau binding at a dilution of 1:106, followed sequentially by MAbs 10-6-1, 6-1-1, and 13-2-6 ( Table 1 ). The concentrations of the antibodies were then adjusted on the basis of their titers relative to that of two active fragments; the 16K and 12K fragments. The levels of reactivity could be qualitatively evaluated based on the intensities of the bands on the immunoblots. Antibody 8-5-7 primarily detected the 12K fragment. The absence of reactivity with the 16K fragment at this dilution (1:106) is not readily explicable, given the fact that the entire 12K fragment was contained within the 16K fragment (see Fig. 6 ). It is possible that there could be a different epitope conformation in the 16K fragment or a different exposure of this epitope on the solid support. Antibody 6-1-1 demonstrated equivalent reactivities with both fragments, as shown by similar intensities on the blot. Both MAbs 13-2-6 and 10-6-1 demonstrated greater reactivities with the 16K fragment. However, the variation of the blotting patterns for the identification of the 16K and 12K fragments provides evidence for the presence of at least two antibody-binding epitopes on the toxin fragments.
The serologic distinction in the two fragments demonstrated by binding of the MAbs was further substantiated by a variation in the mitogenic properties of TSST-1. This activity was analyzed in vitro with toxin fragments as well as with whole toxin. Tenfold dilutions of the eluates containing the 16K and 12K fragments, as well as whole TSST-1, were tested in a conventional mitogenesis assay (Fig. 2) [3H]thymidine incorporated. The responses ranged from 86.5 x 103 to 28.2 x 103 dpm with fragment concentrations of 2.9 x 10-4 to 2.9 x 10-6 nM, respectively. These data showing serial reductions of approximately 55 to 58% in the level of radioactive uptake with each successive dilution could obviate the possibility of nonspecific reactivity. The 16K fragment demonstrated significantly lower responses (P c 0.013) to the corresponding dilutions of the 12K fragment. Although a maximal response of 43.8 x 103 dpm (4.3 x 10-4 nM) was seen with a 1:100 dilution, a rapid decline to background levels was measured with lower dilutions (4.3 x i0-5 and 4.3 x 10-6 nM) of the 16K fragment. The molar concentration of the 16K fragment calculated from the serologic data was approximately 1.5 times greater than that of the 12K fragment. The whole toxin that was eluted from the gel and that was not subject to proteolytic degradation showed equivalent reactivities with all three dilutions (10-2 to 10-4 nM). The similar levels of radioactive uptake by cultures exposed to whole toxin eluted from the gels and a 10-fold higher dilution of native toxin (0.1 nglml [0.84 x 10-5 nM]) suggest that deterioration of the toxin during the isolation procedure from SDS-polyacrylamide gels was minimal. The decline in serologic activities with the 16K and 12K fragments as compared with that of whole toxin was 2.3 and 41%, respectively (Table 2) .
Attention was next focused on the 16K fragment, which exhibited serologic activity, yet it had a diminished mitogenic response when compared with those of the 12K fragment and whole TSST-1. On the basis of this characteristic, the ability of the 16K fragment to abrogate the mitogenicity of the whole toxin was assessed. Human PBMs were initially incubated with various concentrations of the 16K fragment for a period of 24 h preceding the addition of TSST-1. (19) .
% Reduction = [1 -(observed serologic activity/serologic activity relative to that of whole toxin)] x 100.
Significant attenuation of the mitogenic response (P < 0.05) inducible by whole TSST-1 was demonstrated with .10-fold molar excess amounts of the 16K fragment relative to the amount of whole TSST-1 (Fig. 3) . The concentrations of the 16K fragment present in these samples ranged from 2 ng/ml 24 h at 37°C in 5% CO2. The cells were then exposed to an equal volume of whole toxin (0.02 ng/ml; also eluted from SDS-polyacrylamide gels). Cultures were maintained for a further 96 h, and the cells were pulsed with
[3H]thymidine 18 h prior to harvesting. Test samples (16K fragment and whole toxin) are represented by the solid bars (bars 1 to 9). The concentrations of 16K fragment and the molar excess of the 16K fragment relative to that of whole toxin were as follows: 20 ng/ml and >1,000 (bar 1), 2 ng/ml and >100 (bar 2), 1 ng/ml and >50 (bar 3), 0.4 ng/ml and >20 (bar 4) 0.2 ng/ml and >10 (bar 5) 0.1 ng/ml and >5 (bar 6), 0.05 ng/ml and >2.5 (bar 7), 0.02 ng/ml and >1 (bar 8), 8 x 10-3 ng/ml and <0.4 (bar 9). Control samples are represented by the striped bars (bars 1 to 9). Cultures were exposed to the 16K fragment only. Bars This concentration was previously determined as the minimum dosage that was mitogenically effective. As expected, the amount of the 16K fragment approximately equivalent to the minimum stimulatory dosage of whole toxin in the range of 1.7 x 10-6 nM was insufficient to cause any observable suppression on the effect of whole toxin.
The effect of the 16K fragment on mitogenesis was studied further by altering the initial periods of incubation of the PBMs with this fragment for 40 min, 6 h, and 24 h. Measurable suppression with >10-fold molar excess ratios (1.7 x 10-4 to 1.7 x 10-5 nM) of the 16K fragment was evident in a dose-response manner only after 24 h of incubation (Fig.  4C ). Significant inhibitory responses (P < 0.05) were seen with some of the cultures that were initially incubated for 40 min (Fig. 4A) and 6 h (Fig. 4B) with the 16K fragment. However, a decline in radioactive uptake in a dose-response manner, which is reflective of specificity, was evident only on exposure to the 16K fragment for 24 h (Fig. 4C) .
A similar inhibition assay was performed with the 12K fragment. Results from this experiment are shown in Fig. 5 . No attenuation of the mitogenicity of TSST-1 was observed. Based on results of earlier experiments ( Fig. 1 and 2) , the site responsible for mitogenicity is incorporated within the 12K segment of the entire toxin molecule.
The proposed orientation of both active and inactive fragments of TSST-1 on the entire molecule is represented schematically in Fig. 6 . On the basis of serologic reactivity with the MAbs, it is evident that two different antigenic determinant sites are recognized by the MAbs. The first epitope is localized on a 35-amino-acid segment (between residues 53 and 87) which makes up a portion exclusive of the 16K fragment; and the second epitope is on a 106-amino-acid segment (between residues 88 and 194) and constitutes approximately 75% of the 16K fragment and the entire 12K fragment. Additional evidence on the location of these epitopes was derived from the hydrophilicity plot of the entire TSST-1 sequence (data not shown) based on parameters established by Hopp and Woods (11) . These investigators reported that regions of high hydrophilicity on the amino acid sequence of a protein are associated within or adjacent to antigenic determinant sites. The highest peak of hydrophilicity of TSST-1 is located on the hexapeptide making up residues 67 to 73 on the 35-amino-acid segment of the 16K fragment, followed by the region encompassed by residues 119 to 125 on both the 16K and the 12K fragments.
The absence of any demonstrable activity, either serologic or biologic, by the 10K fragment, which represents the NH2-terminal end of the TSST-1 molecule, allows the approximate localization of functional determinants between amino acid residues 53 and 194 (141-amino-acid segment) of the entire molecule. However, the apparent inactivity of the 10K fragment does not necessarily obviate a contribution of this fragment in its native conformation to the activity of the holotoxin.
DISCUSSION
Toxin derivatives from a proteolytic digest of TSST-1 were subjected to serologic and biologic analyses, and the differences between the active fragments were investigated. Further analyses conducted with select MAbs at antibody levels adjusted to exhibit equivalent reactivities with native toxin displayed an unequivocal distinction between the antigenic determinants recognized on the two fragments.
The MAbs recognizing the epitopes were previously evaluated for their ability to neutralize certain biologic effects of Effects of the 12K fragment on the in vitro proliferation of human PBMs exposed to whole TSST-1. The experiment was patterned after the inhibition assay performed with the 16K fragment. The cultures were preincubated with the 12K fragment for 24 h before the addition of whole toxin. Test samples are indicated by solid bars (bars 1 to 6). Cultures were exposed to the 12K fragment and whole toxin. The concentrations of the 12K fragment and the molar excess of the 12K fragment relative to that of whole toxin were as follows: 20 ng/ml and >1,676 (bar 1), 2 ng/ml and >167 (bar 2), 1 ng/ml and >82 (bar 3); 0.4 ng/ml and >34 (bar 4), 0.2 ng/ml and >17 (bar 5), and 0.1 ng/ml and >8 (bar 6). The concentration of whole toxin was 2 x 10-2 ng/ml. Control samples are indicated by striped bars (bars 1 to 6). The cultures were exposed to the 12K fragment only. Bar (17) , it has been reported that the similarities between the amino acid sequences of TSST-1 and staphylococcal enterotoxins A and B are possibly significant, and that with type A streptococcal exotoxin it is probably significant (2). The identification of staphylococcal enterotoxin B secreted by TSST-1-negative S. aureus isolates from nonmenstrual cases of toxic shock syndrome (22) raises questions about the involvement of the related exotoxins in the production of biologic effects similar to those produced by TSST-1.
The second antigenic segment of the TSST-1 molecule was localized on a 35-amino-acid segment encompassed by Arg-53 and Gly-87. This segment was contained within the 16K fragment but not the 12K fragment and was deduced to be a second region because of the reactivity observed with MAbs 10-6-1 and 13-2-1. These MAbs did not demonstrate the neutralizing properties of MAbs 8-5-7 and 6-1-1, indicating that this region of the molecule is not responsible for the biologic parameters mentioned previously. The suppression of mitogenesis in human PBMs exposed to the 16K fragment is suggestive of an alternate biologic property associated with this segment.
The dose-dependent manner by which suppression of the proliferation of mononuclear cells by the 16K fragment is elaborated indicates the relative specificity of the effect. It is evident from the data that in order to instigate any measurable effect on mitogenesis, a minimal 16K fragment to whole toxin molar ratio of at least 10:1 is required. However, the fragments are unlikely to be as stable as undigested toxin. It was also observed that the serologic activity of the fragments was enhanced two-to fourfold with a reduction of SDS from 1.5 to 0.75% in the sample buffet used in electrophoresis. The requirement of a denaturant for the separation of the digestion products is presumably caused by a tendency for the peptides to adhere through a noncovalent interaction.
Complete abrogation of the mitogenic response induced by the whole toxin was not obtained with the use of these fragments. A feasible explanation is that the 12K fragment, which apparently contains the functional region responsible for the mitogenic effect, constitutes a significant portion of the 16K fragment. As a result, partial mitogenicity is still observed that is attributable either to the 16K fragment itself or the whole toxin.
The precise stage of the mitogenic process when inhibition is effective is unknown. The prolonged incubation periods with the fragment prior to the addition of TSST-1 suggest that there is an incursion following the invagination of the fragment or toxin molecule into the cells. This is derived from the relatively rapid half-time (1.5 min) of TSST-1 internalization by human epithelial cells (15) . It is also possible that the prolonged incubation period is mandated in order to establish equilibrium or to instigate a saturable effect. A feasible explanation, however, would be that the 16K fragment contains a conformational variant from the whole toxin and the 12K fragment, thereby allowing receptor binding but obliterating any stimulatory effect.
